FMC-376
Phase 1/2- Indications
- KRAS G12C mutant cancers
Company intelligence / Profile preview
Droia Ventures is a specialist venture capital firm investing globally in early-stage drug development companies focused on oncology and genetic diseases. They support young biotech firms from company creation through clinical proof-of-concept, providing both financial backing and hands-on scientific expertise. Their investments have enabled several programs to reach preclinical and early clinical stages.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Droia Ventures.